duration of prednisolone thrapy in ITP

the comparison of efficacy of 2_week and 3_week prednisolone thrapy in patients with Immune Thrombocytopenic Purpura at Arak Khansari hospital

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201109147553N1

Enrollment

Registered

2011-12-27

Start date

2011-05-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ITP. immune thrombocytopenic purpura

Interventions

Intervention 1: Intervention group: prednisolone (1mg/kg/day) for 2 weeks. Intervention 2: control group: prednisolone (1mg/kg/day) for 3 weeks.

Treatment - Drugs

Intervention group: prednisolone (1mg/kg/day) for 2 weeks

control group: prednisolone (1mg/kg/day) for 3 weeks

Eligibility

Sex/Gender

All

Age

12 Years to 149 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: ITP with thrombocytopenia and normal CBC and normal peripheral blood smear. exclusion criteria: secondary ITP due to some diseases such as: lupus, antiphospholipid syndrom,CLL and infections.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Platelet count. Timepoint: monthly till 6 months after treatment course. Method of measurement: CBC-Diff. and Plt. count/micro liter.	—

Secondary

Measure	Time frame
Blood pressure. Timepoint: before and after treatment course. Method of measurement: via sphygmomanometer. mm.Hg.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.saiedeh Bakhshi

Arak university of medical sciences and health services

bakhshi_saideh@yahoo.com+98 86 1417 3622

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026